GNH USA

Europe — EMA

Lamzede (Velmanase Alfa)

GNH USA supplies Lamzede (Velmanase Alfa), a enzyme replacement therapy for alpha‑mannosidosis. Request a quote for global supply.

Velmanase Alfa

Request sourcing

1
Pack/s

What is Velmanase Alfa?

Velmanase Alfa, the active ingredient in Lamzede, is an enzyme replacement therapy presented as an injection solution for intravenous infusion. It replaces deficient lysosomal alpha‑mannosidase and is used to treat patients with alpha‑mannosidosis, a rare lysosomal storage disorder.

GNH USA supplies Lamzede as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Velmanase Alfa used for?

Lamzede is an enzyme replacement therapy that targets the lysosomal storage pathway in alpha‑mannosidosis.

- Alpha‑mannosidosis: reduces accumulation of mannose‑rich oligosaccharides, helping to improve metabolic function and clinical symptoms.

What are the side effects of Velmanase Alfa?

Lamzede may be associated with a range of adverse reactions observed during or after infusion.

Common Side Effects: - Infusion‑related reactions: flushing, chills, or fever. - Headache or mild dizziness. - Nausea or transient vomiting. - Transient elevation of liver enzymes. - Mild hypotension during infusion.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions. - Severe hypotension or cardiovascular collapse. - Acute respiratory distress or bronchospasm. - Persistent elevation of liver enzymes indicating hepatic injury. - Development of anti‑drug antibodies that may reduce efficacy.

What precautions apply to Velmanase Alfa?

When using Lamzede, clinicians should observe several safety measures.

- Monitor infusion reactions: observe patients closely during and after administration. - Assess liver function: check hepatic enzymes before and periodically during therapy. - Evaluate immunogenicity: test for anti‑drug antibodies if clinical response wanes. - Avoid use in individuals with known hypersensitivity to velmanase alfa or any excipients. - Use with caution in patients with pre‑existing cardiac disease or unstable blood pressure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Velmanase Alfa interact with?

Lamzede can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Live vaccines: concurrent administration may increase risk of infection. - Other enzyme replacement products: may compound immunogenic response.

Moderate Interactions (Monitor Closely): - Antipyretics (e.g., acetaminophen): may mask fever from infusion reactions. - Antihistamines: may alter assessment of allergic responses. - Immunosuppressants: could affect antibody formation and efficacy.

Frequently asked questions

What is Lamzede used for?+
Lamzede is indicated for the treatment of alpha‑mannosidosis, a rare lysosomal storage disease caused by deficiency of the enzyme alpha‑mannosidase. By providing a recombinant form of this enzyme, the therapy helps reduce the buildup of mannose‑rich oligosaccharides in tissues.
How does Velmanase Alfa work?+
Velmanase Alfa is a recombinant human lysosomal alpha‑mannosidase. After intravenous infusion, it is taken up by cells via mannose‑6‑phosphate receptors and delivered to lysosomes, where it restores the missing enzymatic activity needed to break down mannose‑rich oligosaccharides, thereby decreasing their pathological accumulation.
What is the usual dose of Lamzede?+
The specific dose and infusion schedule of Lamzede are determined by the prescribing physician based on the patient’s age, weight, disease severity, and clinical response. Dosing is individualized and should follow the prescriber’s instructions.
Is Lamzede safe during pregnancy or breastfeeding?+
Safety data for Lamzede in pregnancy and lactation are limited. The product’s pregnancy category is not established, so clinicians should weigh potential benefits against unknown risks and discuss options with the patient. Breastfeeding considerations should also be evaluated.
How do I order Lamzede from GNH USA?+
To request Lamzede, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and required import documentation.
How does Lamzede compare with the main alternative drug or class?+
Lamzede is a specific enzyme replacement therapy for alpha‑mannosidosis, whereas alternative approaches may include supportive care, symptomatic treatments, or investigational gene‑therapy strategies. Compared with non‑specific supportive measures, Lamzede directly addresses the underlying enzymatic deficiency, offering a disease‑modifying effect.
What are the storage and handling requirements for Lamzede?+
Lamzede must be stored refrigerated at 2‑8 °C, protected from light, and must never be frozen or shaken. The product should be kept in its original packaging until use to maintain stability and potency.
How is Lamzede administered?+
Lamzede is supplied as an injectable solution for intravenous infusion. The infusion is performed under medical supervision, typically over a period defined by the prescribing physician, with monitoring for infusion‑related reactions.
What are the most serious risks to watch for with Lamzede?+
Serious risks include severe infusion‑related reactions such as anaphylaxis, significant hypotension, respiratory distress, and persistent hepatic enzyme elevation. Prompt recognition and management of these events are essential during and after the infusion.
Who should not use Lamzede?+
Lamzede should be avoided in individuals with known hypersensitivity to velmanase alfa or any of its excipients. Caution is also advised for patients with uncontrolled cardiac disease, severe hepatic impairment, or those who have experienced severe infusion reactions to similar biologics.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Velmanase Alfa
Route
Intravenous Use
Manufacturer
Chiesi Farmaceutici S.P.A.
Origin
EU

Related products

Lamzede

Lamzede

Velmanase Alfa

Chiesi Farmaceutici S.P.A.
EU
Lamzede

Lamzede

Velmanase Alfa

Chiesi Farmaceutici S.P.A.
EU
Lamzede

Lamzede

Velmanase Alfa

Chiesi Farmaceutici S.P.A.
EU